dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Cerebral Hemorrhage in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corkey, C; Jenkins, J; Rollins, M; Tubman, R; Wilson, D | 1 |
| Bourchier, D; Broadbent, R; Darlow, B; Knight, D; Selby, R; Wach, R | 1 |
| Malathi, I; Ng, KC | 1 |
| Asselin, JM; Auten, RL; Belcastro, MR; Brody, AS; Cummings, NJ; Donohue, PK; Egan, EA; Hamm, CR; Hudak, ML; Jansen, RD; Jung, AL; Kimberlin, LV; Martin, DJ; Matteson, EJ; Montgomery, P; Riddlesberger, MM; Rosenberg, AA | 1 |
| Anday, E; Easa, D; Gong, A; LeBlanc, M; Long, W; Pauly, T; Pramanik, A; Sell, M; Stevenson, D; Walther, F | 1 |
| Ma, EJ; van de Bor, M; Walther, FJ | 1 |
5 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Cerebral Hemorrhage
| Article | Year |
|---|---|
Comparison of clinical responses to natural and synthetic surfactants.
Topics: Arteries; Biological Products; Cerebral Hemorrhage; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Oxygen; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Alveoli; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn | 1993 |
Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Topics: Birth Weight; Cerebral Hemorrhage; Cohort Studies; Cost of Illness; Drug Combinations; Fatty Alcohols; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Male; New Zealand; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Prenatal Care; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Steroids; Survival Rate; Ultrasonography | 1994 |
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Topics: Age Factors; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Data Interpretation, Statistical; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Linear Models; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome | 1997 |
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Analysis | 1992 |
Cerebral blood flow velocity after surfactant instillation in preterm infants.
Topics: Blood Flow Velocity; Cerebral Hemorrhage; Cerebrovascular Circulation; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1991 |
1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Cerebral Hemorrhage
| Article | Year |
|---|---|
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemodynamics; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Ventilation; Remission Induction; Respiration, Artificial; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ventilation-Perfusion Ratio | 1995 |